Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06880653 · ClinicalTrials.gov registry record · NA

Dose Response of Exercise for Arthritis Management

A NA study of Osteoarthritis and Arthritis, sponsored by University of South Carolina.

Recruiting
Registry status
NA
Development phase
285
Enrollment target
1
Study location

NCT06880653: Recruiting NA study of Osteoarthritis and Arthritis, sponsored by University of South Carolina.

NCT06880653 is a NA study of Osteoarthritis and Arthritis that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 285 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06880653, a NA study of Osteoarthritis and Arthritis, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
NA
Development phase
285 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.

Primary Outcome

Change in distance walked during the 6 minute walk test

Interventions

  • BEHAVIORAL DREAM Adaptive Intervention

Study Locations (1)

South Carolina

  • University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 285 participants
Start Date 2025-03-28
Est. Completion 2029-04-30
Phase NA
University of South Carolina

157 total trials

What NCT06880653 shows while recruiting

NCT06880653 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (65% lower).

The record links to 6 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which DREAM Adaptive Intervention is the first listed.

NCT06880653 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06880653 about?

NCT06880653 is a clinical study titled "Dose Response of Exercise for Arthritis Management". The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.

What is the current status of trial NCT06880653?

This trial is currently recruiting. It is a NA study. The enrollment target is 285 participants. The study started on 2025-03-28. Estimated completion is 2029-04-30.

What conditions does trial NCT06880653 study?

This clinical trial studies the following conditions: Osteoarthritis, Arthritis, Gout, Lupus Erythematosus, Systemic, Rheumatoid Arthritis (RA).

What interventions are being tested in trial NCT06880653?

The interventions under investigation include: DREAM Adaptive Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06880653?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06880653 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06880653's enrollment target sits among peer trials

285 42nd of 135 higher than 94 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03412877 · 285 participants · Phase 2

    Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

  • NCT04537936 · 285 participants · NA

    Psychotherapy Intervention for Latinos With Adv Cancer

  • NCT04965675 · 285 participants · Phase 3

    A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

  • NCT05320835 · 285 participants · NA

    A Setting Focus Overdose Prevention Intervention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06880653, the US trial registry maintained by the National Library of Medicine. NCT06880653 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.